The Health Canada Medical Device Licence is the licence that manufacturers need under the Medical Devices Regulations (SOR/98-282) for Class II, III, and IV medical devices. A prerequisite is a quality management system certificate, which must come from an MDSAP-recognized auditing organization. Class I devices do not need a product licence.
Definition and legal basis
The Medical Device Licence is the authorization that Health Canada issues under the Medical Devices Regulations (SOR/98-282) for Class II, III, and IV medical devices. Without this licence, no one may import or sell such a device in Canada. The application is submitted by the manufacturer, and the licence applies to the individual device (sections 26 and 32). According to the Canadian government's legal database, the Regulations are current to September 21, 2026 and were last amended on June 17, 2026 (as of October 2026).
A Medical Device Licence is not the same as an Establishment Licence (a licence for the establishment, that is, the business site). The Establishment Licence concerns importers and distributors and is described in the section on licence types. Unlike in the United States, where the FDA clears or approves devices through procedures such as 510(k) (Premarket Notification) or PMA (Premarket Approval), in Canada the licence is the central instrument for Classes II to IV.
Risk classes I to IV
Under section 6, medical devices are assigned to Classes I to IV using the classification rules in Schedule 1. Class I stands for the lowest risk, Class IV for the highest. If a device fits into several classes, the higher one applies (section 7). Part 1 of Schedule 1 contains rules for devices other than in vitro diagnostic devices, and Part 2 contains rules for in vitro diagnostic devices.
The classification follows the nature and purpose of the device. For example, under Rule 11, an active device intended to administer substances, where the administration is potentially hazardous, is Class III. If it controls the treatment through a closed loop, it is Class IV. Under Rule 12, any other active device is Class I. The term FDA Device Classification shows the comparison with the US system.
Medical Device Licence and Establishment Licence
Under section 26, the obligation to hold a Medical Device Licence applies only to Classes II, III, and IV. For Class I devices, the Regulations require no product licence. Class I manufacturers nevertheless generally need an Establishment Licence: section 44 prohibits import and sale without one. Exempt are, among others, retailers, health care institutions, and manufacturers of Classes II to IV. A Class I manufacturer is exempt only if it imports or distributes exclusively through a holder of an Establishment Licence.
Custom-made devices and devices for Special Access (Part 2 of the Regulations), clinical trials in humans (Part 3), and devices for an urgent health need (Part 1.1) follow their own rules and are not covered here.
Content of the licence application
Section 32 specifies what the application must contain. For all classes, these are the name, class, and identifier of the device, as well as the name and address of the manufacturer and of the manufacturer's site. Further documents are added depending on the class.
| Class | Additional documents (selection from section 32) |
|---|---|
| II | Description of the medical purposes and uses, list of the standards applied, confirmation by a senior official that objective evidence exists for the requirements of sections 10 to 20, copy of the label, quality management system certificate. |
| III | In addition, a description of the device and its materials, countries of previous sales including reported problems and recalls, a summary of all studies, a bibliography. The certificate covers design and manufacture. |
| IV | In addition, a risk assessment with risk reduction measures, a quality plan, material specifications, the manufacturing process, and detailed information on preclinical and clinical studies, process validation and, where applicable, software validation. |
The Minister must refuse the licence if the device does not meet the requirements of sections 10 to 20 (section 38). The Minister may refuse it for violations of the labeling provisions of sections 21 to 23. An issued licence can be suspended, among other grounds, if the device no longer meets the requirements or the quality management system proves insufficient in light of new findings (section 40).
MDSAP certificate as a prerequisite
For Classes II, III, and IV, the Regulations require a certificate that the quality management system meets the Canadian version of ISO 13485 (section 32, subsection 2 paragraph f, subsection 3 paragraph j, and subsection 4 paragraph p). It must come from a registrar that the Minister has recognized under section 32.1. The certificate is valid for three years at most (section 32.2). A new or amended certificate must be submitted to the Minister within 30 days (section 43.1).
In its guidance, Health Canada describes that an MDSAP auditing organization corresponds to the registrar of the Regulations and that the certificate must come from an MDSAP-recognized auditing organization. The responsible directorate (the Therapeutic Products Directorate) accepts the registration unless there is reason to doubt its validity. According to the transition notice from Health Canada, manufacturers of these classes had to switch from the former Canadian system to the MDSAP (Medical Device Single Audit Program), even for distribution in Canada only. This part of the notice dates from the transition period, so the manufacturer should check the current status with Health Canada. The standard itself is covered by the term ISO 13485 (Quality Management System for Medical Devices).
Human factors and usability
The Medical Devices Regulations contain no separate chapter on usability or human factors and do not use these terms (own full-text search, therefore an own inference). The connection arises through the safety requirements. Under section 10, the manufacturer must identify risks, eliminate or reduce them where possible, and provide information on the remaining risks. Under section 21, the label needs instructions for use where they are necessary for safe and effective use, and all information must be easily understandable to the intended user. This concerns in particular the Instructions for use (IFU).
For in vitro diagnostic devices intended for use at the point of care by the patient, the Regulations expressly require testing with persons who correspond to the intended users, under conditions similar to actual use. For Class II, a confirmation from the manufacturer is sufficient; for Class III, a summary; for Class IV, detailed information must be submitted (section 32, subsection 2 paragraph e, subsection 3 paragraph h, subsection 4 paragraph k).
A Health Canada guidance on clinical evidence addresses usability in more detail (page as of April 1, 2026). It treats usability as an aspect to be considered for all patient groups. Usability and human factors studies use typical users in a simulated clinical environment. For the definition of usability testing, the guidance cites the standard IEC 62366-1. It states that human factors evidence may be necessary to show that known risks have been reduced as far as possible. How such evidence is built up in practice is shown by the term Summative usability evaluation.
A separate Health Canada guidance prescribing a particular human factors method for the licence application was not found in this research and is therefore not asserted here.
The Medical Device Licence is Health Canada's product-specific authorization for Class II, III, and IV medical devices. The legal basis is the Medical Devices Regulations (SOR/98-282). Class I devices need no product licence, but their manufacturers and distributors generally need an Establishment Licence.
The application becomes more extensive with each class. Common to all classes is the quality management system certificate under the Canadian version of ISO 13485, which according to Health Canada must come from an MDSAP-recognized auditing organization.
Usability is not regulated as a separate term in the Regulations. The connection arises through the safety requirements, the instructions for use, and, for certain diagnostic devices, testing with representative users. Health Canada addresses usability studies in a guidance on clinical evidence.
Frequently asked questions (FAQ)
Which classes need a Medical Device Licence?
Classes II, III, and IV. Under section 26 of the Medical Devices Regulations, such a device may be imported or sold only if the manufacturer holds a licence for it. For Class I, the Regulations require no product licence.
Does a Class I device need no licence at all?
No product licence, but usually an Establishment Licence for import and distribution. A Class I manufacturer is exempt only if it imports or distributes exclusively through a holder of an Establishment Licence (section 44).
Is an MDSAP certificate mandatory?
For Classes II to IV, the Regulations require a quality management system certificate from a recognized registrar. According to Health Canada's guidance, it must come from an MDSAP-recognized auditing organization. The manufacturer should check current details with Health Canada.
Is there a separate human factors guidance for the licence in Canada?
This research found no Health Canada guidance that prescribes a human factors method for the licence application. The guidance on clinical evidence addresses usability studies and cites IEC 62366-1.
How long is the quality management certificate valid?
It is valid for three years at most (section 32.2). A new or amended certificate must be submitted to the Minister within 30 days (section 43.1).
Are you planning approval in Canada? We help you build the usability evidence so that it also supports further markets.
More about our usability engineeringSources
- ISO 13485:2016, Medical devices, Quality management systems, Requirements for regulatory purposes
- IEC 62366-1:2015+AMD1:2020, Medical devices, Part 1: Application of usability engineering to medical devices
- Medical Devices Regulations, SOR/98-282 (version current to September 21, 2026)
- Health Canada: Requirements in the Recognition Process for MDSAP Auditing Organizations
- Health Canada: Notice, MDSAP Transition Plan, Frequently Asked Questions
- Health Canada: Guidance on clinical evidence requirements for medical devices, Clinical data and evaluation